Test “BetterEveryDay” patient-reported care for pancreatic or bile cancer
Part of Cancer, Digestive system, Hormones & metabolism, Lungs & breathing clinical trials.
This study studies how a patient “reporting” program (called PRO) works for people with advanced pancreatic or bile-tract cancer. It may help teams understand symptoms and needs earlier to improve care and support during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have confirmed advanced pancreatic or bile-tract cancer (diagnosed by biopsy/cytology)
- You are able to start your first anti-cancer treatment within the next 2 weeks
- You are generally able to function day-to-day (performance status 0–2)
- You have internet access and can answer study questions (by yourself or with help from an interpreter/family)
- You agree to sign informed consent before any study steps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This study looks at how lifestyle factors may affect how well chemotherapy works for pancreatic cancer. If you join, researchers will track your treatment and daily habits to learn more about what helps people respond better.
This research study examines circulating tumor cells (cancer cells in the bloodstream) to better understand which patients might benefit from PARP inhibitor drugs. You'll have blood samples collected to help doctors personalize cancer treatment decisions.
This study uses data from patients with pancreatic conditions and healthy people to improve care through computer analysis. It may help researchers develop better tools for diagnosis and treatment.
This trial uses electronic surveys to identify symptoms and unmet needs in people with advanced cancer, then connects them to palliative care services. It aims to improve quality of life by making sure patients get the extra support they need.
This study tests a personalized website program called COMPASS designed to help people with stage I-III pancreatic cancer improve their exercise and diet while receiving chemotherapy before surgery. The goal is to see if this program helps patients feel better and stay stronger during treatment.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.